LZTS1

leucine zipper tumor suppressor 1, the group of Leucine zipper tumor suppressor family

Basic information

Region (hg38): 8:20246165-20303963

Links

ENSG00000061337NCBI:11178OMIM:606551HGNC:13861Uniprot:Q9Y250AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LZTS1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LZTS1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
81
clinvar
9
clinvar
90
missense
154
clinvar
14
clinvar
6
clinvar
174
nonsense
1
clinvar
1
start loss
0
frameshift
2
clinvar
2
inframe indel
6
clinvar
6
splice donor/acceptor (+/-2bp)
0
splice region
1
4
1
6
non coding
8
clinvar
9
clinvar
17
Total 0 0 163 103 24

Variants in LZTS1

This is a list of pathogenic ClinVar variants found in the LZTS1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-20249712-A-T LZTS1-related disorder Benign (Nov 06, 2019)3052596
8-20249727-T-A Uncertain significance (Apr 06, 2023)2852918
8-20249749-G-A not specified Likely benign (Mar 19, 2024)3292436
8-20249758-G-A Likely benign (Jul 06, 2022)1912418
8-20249763-C-T not specified Conflicting classifications of pathogenicity (Oct 12, 2024)2180682
8-20249764-C-A Likely benign (Mar 10, 2023)3012228
8-20249772-G-C Uncertain significance (Mar 23, 2023)2837897
8-20249784-A-G Likely benign (Oct 27, 2022)3003757
8-20249790-C-G Uncertain significance (Jun 25, 2022)1952707
8-20249794-G-A Likely benign (May 11, 2022)1948391
8-20249796-C-T not specified Uncertain significance (Oct 26, 2023)2233226
8-20249797-G-A Likely benign (Oct 27, 2022)2707605
8-20249807-C-T Uncertain significance (Mar 03, 2023)1346561
8-20249808-G-A Uncertain significance (Nov 18, 2023)2724619
8-20249811-C-G Uncertain significance (Nov 19, 2023)2177992
8-20249814-G-C Benign (Jan 26, 2024)1670859
8-20249820-G-C Uncertain significance (Jun 13, 2023)2811524
8-20249833-C-T Benign (Oct 23, 2023)1674665
8-20249837-C-T Uncertain significance (Dec 22, 2022)2977473
8-20249838-G-A LZTS1-related disorder • not specified Uncertain significance (Mar 20, 2023)2513322
8-20249845-C-G Likely benign (Jun 21, 2022)2007591
8-20249846-C-T Uncertain significance (Aug 31, 2022)1441624
8-20249847-G-A Uncertain significance (Jul 25, 2023)2989186
8-20249862-C-T Uncertain significance (Jan 29, 2024)2722757
8-20249863-G-A Likely benign (Jul 15, 2022)2420534

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LZTS1protein_codingprotein_codingENST00000381569 357799
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9550.0451125740061257460.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2173593710.9680.00002563831
Missense in Polyphen119136.680.870641502
Synonymous0.1001741760.9900.00001251217
Loss of Function3.56218.50.1087.99e-7225

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005800.0000580
Ashkenazi Jewish0.000.00
East Asian0.00005490.0000544
Finnish0.000.00
European (Non-Finnish)0.00001840.0000176
Middle Eastern0.00005490.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the regulation of cell growth. May stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. May act as a tumor suppressor. {ECO:0000269|PubMed:10097140, ECO:0000269|PubMed:11464283, ECO:0000269|PubMed:11504921}.;
Disease
DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:10097140}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.219

Intolerance Scores

loftool
0.118
rvis_EVS
0.4
rvis_percentile_EVS
76.49

Haploinsufficiency Scores

pHI
0.211
hipred
Y
hipred_score
0.707
ghis
0.575

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.907

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lzts1
Phenotype
cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
transcription, DNA-templated;regulation of transcription, DNA-templated;negative regulation of macroautophagy;mitotic cell cycle phase transition
Cellular component
cytoplasm;postsynaptic density;cell junction;dendritic spine;postsynaptic membrane
Molecular function
DNA binding;DNA-binding transcription factor activity;protein binding;microtubule binding